Healthleap Raises $38 Million for Hospital Risk Screening AI
Oct 07, 2026
Funding
Thyme Care Raises Over $125 Million and Forms Thyme Companies
Sep 2, 2026
Thyme Care raised over $125 million in Series E funding led by Morgan Health and formed Thyme Companies, a parent entity for new oncology businesses.
Thyme Care raised over $125 million in Series E funding led by Morgan Health, with participation from Humana, CVS Health Ventures, and other investors, the company announced in a press release.
Other participants included AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health. Thyme Care said its services are available to more than 10.5 million people across all 50 states and that it manages more than $7 billion in oncology spending.
Alongside the funding, Thyme Care formed Thyme Companies as a parent entity for new independent oncology businesses. Areas in active development include adoption of lower cost biosimilars and clinical trial accrual, with the first business expected to launch later this year.
Co founder Robin Shah will serve as executive chairman of Thyme Companies. Thyme Care will continue under CEO Brad Diephuis, with Bobby Green serving as president and chief medical officer.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 20 Jooba Raises $4 Million for AI Recruiting Service Oct 20 Firefly Technology Raises $20 Million for AI Safety Platform Oct 20 AuxoAI Raises $20.7 Million for Enterprise AI Consulting Oct 20 Vectorial Raises $3 Million for AI Consumer Simulations Oct 20 CBRE agrees to acquire Onnec for up to £760 millionMore from Life Sciences
Oct 20 Penn's Percival AI Flags Hidden Disease Signals in Routine CT Scans Oct 20 AstraZeneca and Oracle Partner on AI for Clinical Trials Oct 20 XRlabs Raises €7.48 Million for Surgical AI Oct 20 AI Estimates Cancer Survival From a Face Photo Oct 19 E(3)-Pose Tracks Fetal Movement During MRI ScansFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Heidi Raises $340 Million for Health Care AI Expansion
Sep 23, 2026
Funding
Parakeet Health raises $10 million for AI patient access platform
Oct 01, 2026
Funding
Healthcare Triangle Pursues Up to $30 Million Roboticom Asset Deal
Sep 23, 2026
Acquisitions
Basecamp Research Raises $140 Million for AI Designed Therapeutics
Sep 24, 2026
Funding
AstraZeneca and Oracle Partner on AI for Clinical Trials
Oct 20, 2026
Healthcare
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.